WallStreetZenWallStreetZen

NASDAQ: LXEO
Lexeo Therapeutics Inc Stock Ownership - Who owns Lexeo Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lexeo Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Richard Nolan TownsendChief Executive Officer2026-07-0125,947$4.48
$116.24kSell
Louis Edward TamayoChief Financial Officer2026-07-014,641$4.49
$20.84kSell
Jose Manuel OteroChief Operating Officer2026-07-014,666$4.48
$20.90kSell
Narinder Pal BhallaChief Medical Officer2026-07-0122,306$4.42
$98.59kSell
Jose Manuel OteroChief Operating Officer2026-05-181,302$5.07
$6.61kSell
Richard Nolan TownsendChief Executive Officer2026-05-183,342$5.07
$16.93kSell
Richard Nolan TownsendChief Executive Officer2026-04-0655,000$5.69
$313.12kSell
Jose Manuel OteroChief Operating Officer2026-03-135,930$2.64
$15.68kBuy
Richard Nolan TownsendChief Executive Officer2026-03-132,623$2.64
$6.94kBuy
Richard Nolan TownsendChief Executive Officer2026-02-1810,173$6.38
$64.92kSell

1 of 4

LXEO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LXEO insiders and whales buy or sell their stock.

LXEO Shareholders

What type of owners hold Lexeo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Paradigm Biocapital Advisors LP7.88%6,184,134$26.90MInstitution
Blackrock Inc6.51%5,110,871$22.23MInstitution
Affinity Asset Advisors LLC6.43%5,050,211$21.97MInstitution
Ra Capital Management LP6.37%5,000,000$21.75MInstitution
Janus Henderson Group PLC6.34%4,976,429$21.65MInstitution
Vestal Point Capital LP5.70%4,475,000$19.47MInstitution
Frazier Life Sciences Management LP5.64%4,424,725$19.25MInstitution
Citadel Advisors LLC4.88%3,834,999$16.68MInstitution
Orbimed Advisors LLC4.59%3,602,450$15.67MInstitution
State Street Corp4.54%3,568,242$15.52MInstitution

1 of 3

LXEO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LXEO91.36%8.64%Net SellingNet Selling
PALI84.51%7.00%Net SellingNet Selling
FENC4.51%95.49%Net SellingNet Buying
AGEN6.56%93.44%Net BuyingNet Buying
ZNTL58.13%41.87%Net Selling
View Top Biotech Stocks

Lexeo Therapeutics Stock Ownership FAQ

Who owns Lexeo Therapeutics?

Lexeo Therapeutics (NASDAQ: LXEO) is owned by 101.74% institutional shareholders, 9.62% Lexeo Therapeutics insiders, and 0.00% retail investors. Longitude Capital Partners IV LLC is the largest individual Lexeo Therapeutics shareholder, owning 2.57M shares representing 3.27% of the company. Longitude Capital Partners IV LLC's Lexeo Therapeutics shares are currently valued at $10.60M.

If you're new to stock investing, here's how to buy Lexeo Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.